Nichole Churchman
Family Medicine · Leesville, LANPI 1700916095
Payments from drug & device makers
Across 244 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$751
- Novo Nordisk$614
- AbbVie$603
- AstraZeneca$499
- Lilly USA, LLC$161
- GSK$153
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,990100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,996 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 150 | $181,321 |
| MounjaroTirzepatide | 94 | $119,188 |
| EliquisApixaban | 187 | $107,357 |
| JardianceEmpagliflozin | 64 | $67,128 |
| FarxigaDapagliflozin Propanediol | 43 | $49,901 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $45,785 |
| TrulicityDulaglutide | 44 | $42,421 |
| LinzessLinaclotide | 52 | $41,340 |
| RybelsusSemaglutide | 32 | $37,353 |
| CreonLipase/Protease/Amylase | 17 | $36,887 |
| JanuviaSitagliptin Phosphate | 25 | $31,865 |
| XareltoRivaroxaban | 22 | $25,495 |
| MyrbetriqMirabegron | 24 | $23,391 |
| Tresiba Flextouch U-100Insulin Degludec | 39 | $22,919 |
| UbrelvyUbrogepant | 11 | $18,390 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $614 | $218,674182 claims |
| Lilly USA, LLCMounjaro, Trulicity | $161 | $161,609138 claims |
| PfizerEliquis | $69 | $107,357187 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta | $751 | $100,388107 claims |
| AbbVieLinzess, Creon, Ubrelvy | $603 | $96,61780 claims |
| AstraZenecaFarxiga, Symbicort | $499 | $53,13454 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $153 | $51,00562 claims |
| MerckJanuvia, Janumet | $30 | $41,84340 claims |
| Johnson & JohnsonXarelto | $12 | $25,49522 claims |
| Astellas Pharma US IncMyrbetriq | $152 | $23,39124 claims |
| NovartisEntresto | $127 | $16,39313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Leesville
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
- Kristen ThomasNew Orleans$361K
- Clint WilsonBossier City$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.